{
  "title": "Strategies for targeting chondrosarcomas in vivo and molecular dissection of oncogenic events in chondrosarcomas: is epigenetics the culprit?",
  "authors": [
    "RÃ©doane Daoudi"
  ],
  "submission_date": "2023-07-30T13:43:33+00:00",
  "revised_dates": [],
  "abstract": "It is obvious that both epigenetic and non-epigenetic actors contribute to tumorigenesis in chondrosarcomas and more generally in other cancers. Thus, the main altered pathways in chondrosarcomas are now well established and include both epigenetic and non-epigenetic pathways such as the PI3K-AKT signaling, EGFR overexpression, SPARC overexpression, c-myc overexpression, IHH/GLI1 axis, loss of Rb function, HIF1-alpha stabilization, IDH1 mutations, hypermethylation and SIRT1. This review aims to provide a detailed analysis of these pathways and highlights recurrent interactions between non-epigenetic and epigenetic actors in chondrosarcomas, raising the intriguing possibility of developing therapeutics targeting both epigenetic and non-epigenetic actors and supporting data from previous studies. Finally, we propose some strategies for targeting chondrosarcomas in vivo based on properties of this tumor.",
  "categories": [
    "q-bio.MN",
    "q-bio.SC"
  ],
  "primary_category": "q-bio.MN",
  "doi": null,
  "journal_ref": null,
  "arxiv_id": "2307.16231",
  "pdf_url": "https://arxiv.org/pdf/2307.16231v1",
  "comment": "21 pages, 1 figure, 1 table",
  "num_versions": null,
  "size_before_bytes": 503394,
  "size_after_bytes": 300388
}